Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2011 Publisher: Alcon Laboratories (UK) Limited Pentagon Park Boundary Way Hemel Hempstead Hertfordshire HP2 7UD United Kingdom
IOPIDINE 5mg/ml Eye Drops, Solution.
| Pharmaceutical Form |
|---|
|
Eye drops, solution. A colourless to pale yellow solution. |
1 ml of solution contains Apraclonidine 5 mg (as hydrochloride).
Excipients: 1 ml of solution contains 0.1 mg benzalkonium chloride
For a full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Apraclonidine |
Apraclonidine is an α2-adrenergic receptor agonist and a weak α1-adrenergic receptor agonist. It is used for the prevention and treatment of postsurgical intraocular pressure elevation. |
| List of Excipients |
|---|
|
Benzalkonium chloride |
5 ml and/or 10 ml white LDPE DROP-TAINER dispensers with a natural LDPE dispensing plug and white polypropylene closure.
Not all pack sizes may be marketed.
Alcon Laboratories (UK) Limited
Pentagon Park
Boundary Way
Hemel Hempstead
Hertfordshire HP2 7UD
United Kingdom
PL 00649/0132
29 December 1994/Renewed 20 October 2010
| Drug | Countries | |
|---|---|---|
| IOPIDINE | Austria, Australia, Canada, Finland, France, Ireland, Israel, Malta, Netherlands, New Zealand, Tunisia, United Kingdom, United States |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
